(Q36508862)
Statements
Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab (English)
Annette Wundes
Kai-Hsin Chang
Sylvia Lucas
Thalia Papayannopoulou
14 January 2008
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference